Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

NorwayBack to Norway

Clinical trials in Kristiansand – page 2

40 clinical trials in Kristiansand, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

NorwayOur site in NorwayKliniske-Studier.no(opens in a new tab)
Kristiansand at a glance
40
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

40 trials in Kristiansand

Open in trial search

Immune thrombocytopenia

Recruiting

Study Comparing Avatrombopag and Rituximab for Adults with Immune Thrombocytopenia Not Responding to Corticosteroids

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Avatrombopag
  • Sponsor:Ostfold Hospital Trust

Glioblastoma

Recruiting

Study on Lomustine and Temozolomide for Newly Diagnosed Glioblastoma Patients

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Region Oestergoetland

Respiratory tract infection viral

Recruiting

Study on Stopping Antibiotics in Adults with Viral Respiratory Infections Using Tetracyclines and Other Antibiotics

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Sponsor:Akershus University Hospital

Hormone-refractory prostate cancer+2

Recruiting

Study on the Effectiveness of Abiraterone, Capivasertib, and Enzalutamide in Patients with Metastatic Prostate Cancer

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Karolinska Institutet

Cerebrovascular accident

Recruiting

Study on Tranexamic Acid and Sodium Chloride for Patients with Stroke-Related Brain Bleeding

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:University Of Nottingham

Multiple sclerosis

Recruiting

Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Helse Bergen HF

Malignant melanoma

Recruiting

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Deafness neurosensory

Recruiting

Study of Hyperbaric Oxygen Therapy Combined with Standard Treatment for Patients with Sudden Hearing Loss

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Nitrous Oxide
  • Sponsor:Helse Bergen HF

Long QT syndrome

Not yet recruiting

Effect of estradiol‑based menopausal hormone therapy drug combination on QTc in peri‑ and postmenopausal women with genetically confirmed Long QT syndrome

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Estradiol
  • Sponsor:Oslo University Hospital HF

Small cell lung cancer limited stage

Not yet recruiting

Durvalumab after chemoradiation for patients with limited‑stage small cell lung cancer: a randomized trial of high‑dose versus standard thoracic radiation

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Norwegian University Of Science And Technolology

Juvenile idiopathic arthritis

Not yet recruiting

Maintenance versus tapered TNF‑alpha inhibitor therapy (golimumab, etanercept, adalimumab) in children and adolescents with juvenile idiopathic arthritis

Registered drugNo placebo
Countries:NorwayNorway
  • Participants:0–17 years
  • Substances:Adalimumab
  • Sponsor:Oslo University Hospital HF

Small fibre neuropathy

Not yet recruiting

Study on the Effect of Human Normal Immunoglobulin and Sodium Chloride on Pain Relief in Patients with Idiopathic Painful Sensory Neuropathy

Registered drug
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Sodium Chloride
  • Sponsor:Sorlandet Sykehus HF

Other cities in Norway

The busiest research cities in the country

All 54 cities in Norway

Clinical research in Kristiansand

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on precision cancer medicine for various types of malignancies, including studies on rare cancers and targeted therapies.

  • Colorectal Cancer Treatment
  • Prostate Cancer Therapies
  • Lung Cancer Management

Studies evaluating novel drug combinations and biomarker-driven treatment approaches.

02 Gynecologic Oncology

Research focusing on advanced treatments for ovarian and endometrial cancers, investigating maintenance therapies and immunotherapy combinations.

  • Platinum-Resistant Ovarian Cancer
  • Endometrial Cancer Therapies
  • Combination Immunotherapy

Evaluating targeted therapies and novel treatment combinations for improved patient outcomes.

03 Neurological Conditions

Studies addressing various neurological disorders, including glioblastoma treatment and stroke management protocols.

  • Brain Cancer Therapies
  • Stroke Treatment
  • Neuropathy Management

Investigating innovative therapeutic approaches and combination treatments.

04 Autoimmune Disorders

Clinical research examining treatments for rheumatoid arthritis and immune-related conditions, focusing on therapeutic drug monitoring.

  • Rheumatoid Arthritis Management
  • Immune Thrombocytopenia
  • Targeted Therapies

Evaluating treatment efficacy and monitoring strategies for improved patient care.

Back to NorwayAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.